Susquehanna International Group’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-18,400
Closed -$238K 14020
2021
Q3
$238K Buy
+18,400
New +$293K ﹤0.01% 11115
2021
Q1
Sell
-18,500
Closed -$290K 12925
2020
Q4
$290K Sell
18,500
-55,700
-75% -$1.03M ﹤0.01% 9334
2020
Q3
$1.42M Sell
74,200
-14,400
-16% -$249K ﹤0.01% 5290
2020
Q2
$1.22M Sell
88,600
-12,600
-12% -$177K ﹤0.01% 5467
2020
Q1
$1.07M Buy
101,200
+66,500
+192% +$1.08M ﹤0.01% 5236
2019
Q4
$648K Sell
34,700
-19,000
-35% -$245K ﹤0.01% 6423
2019
Q3
$562K Sell
53,700
-24,100
-31% -$196K ﹤0.01% 7030
2019
Q2
$590K Sell
77,800
-7,700
-9% -$67K ﹤0.01% 6932
2019
Q1
$942K Buy
85,500
+48,400
+130% +$392K ﹤0.01% 5158
2018
Q4
$188K Buy
37,100
+4,800
+15% +$19.7K ﹤0.01% 7805
2018
Q3
$103K Hold
32,300
﹤0.01% 8597
2018
Q2
$145K Buy
32,300
+6,300
+24% +$28.5K ﹤0.01% 8867
2018
Q1
$139K Sell
26,000
-18,300
-41% -$84.3K ﹤0.01% 8565
2017
Q4
$175K Sell
44,300
-36,500
-45% -$154K ﹤0.01% 8389
2017
Q3
$353K Buy
80,800
+38,700
+92% +$183K ﹤0.01% 7114
2017
Q2
$198K Sell
42,100
-74,000
-64% -$709K ﹤0.01% 8302
2017
Q1
$1.91M Buy
116,100
+67,200
+137% +$880K ﹤0.01% 3819
2016
Q4
$495K Buy
48,900
+5,500
+13% +$73.2K ﹤0.01% 7022
2016
Q3
$584K Buy
+43,400
New +$637K ﹤0.01% 5776

Other funds holding XBIT

Susquehanna International Group's XBIT Position: Q3 2025 in Review

Susquehanna International Group sold out of XBiotech (XBIT) in Q3 2025, closing a stake of 39,381 shares — an estimated $117K sold.

Susquehanna International Group first reported a position in XBIT in Q3 2016 and held it in 22 quarters. The position peaked at $1.38M in Q1 2024. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.

  • Susquehanna International Group reported no remaining XBiotech position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 39,381 XBiotech shares in Q3 2025, an estimated $117K.
  • Susquehanna International Group first reported a position in XBiotech in Q3 2016 and held it in 22 quarters.
  • Susquehanna International Group's XBiotech position peaked at $1.38M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.